• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黏液瘤病毒M-T7是一种分泌型γ干扰素受体同源物,是欧洲兔黏液瘤病发展的关键毒力因子。

Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits.

作者信息

Mossman K, Nation P, Macen J, Garbutt M, Lucas A, McFadden G

机构信息

Department of Biochemistry, University of Alberta, Edmonton, Canada.

出版信息

Virology. 1996 Jan 1;215(1):17-30. doi: 10.1006/viro.1996.0003.

DOI:10.1006/viro.1996.0003
PMID:8553583
Abstract

Myxoma virus is a leporipoxvirus of New World rabbits (Sylvilagus sp.) that induces a rapidly lethal infection known as myxomatosis in the European rabbit (Oryctolagus cuniculus). Like all poxviruses, myxoma virus encodes a plethora of proteins to circumvent or inhibit a variety of host antiviral immune mechanisms. M-T7, the most abundantly secreted protein of myxoma virus-infected cells, was originally identified as an interferon-gamma receptor homolog (Upton, Mossman, and McFadden, Science 258, 1369-1372, 1992). Here, we demonstrate that M-T7 is dispensable for virus replication in cultured cells but is a critical virulence factor for virus pathogenesis in European rabbits. Disruption of both copies of the M-T7 gene in myxoma virus was achieved by the deletion of 372 bp of M-T7 coding sequences, replacement with a selectable marker, p7.5Ecogpt, and selection of a recombinant virus (vMyxlac-T7gpt) resistant to mycophenolic acid. vMyxlac-T7gpt expressed no detectable M-T7 protein and infected cells supernatants were devoid of any detectable interferon-gamma binding activities. Immunohistochemical staining with anti-beta-galactosidase and anti-CD43 antibodies demonstrated that in vMyxlac-T7gpt-infected rabbits the loss of M-T7 not only caused a dramatic reduction in disease symptoms and viral dissemination to secondary sites, but also dramatically influenced host leukocyte behavior. Notably, primary lesions in wild-type virus infections were generally underlayed by large masses of inflammatory cells that did not effectively migrate into the dermal sites of viral replication, whereas in vMyxlac-T7gpt infections this apparent block to leukocyte influx was relieved. A second major phenotypic distinction noted for the M-T7 knockout virus was the extensive activation of lymphocytes in secondary immune organs, particularly the spleen and lymph nodes, by Day 4 of the infection. This is in stark contrast to infection by wild-type myxoma virus, which results in relatively little, if any, cellular activation of germinal centers of spleen and lymph node by Day 4. We conclude that M-T7 functions early in infection to (1) retard inflammatory cell migration into infected tissues and (2) disrupt the communication between sentinel immune cells at the site of primary virus infection in the subdermis and lymphocytes in the secondary lymphoid organs, thereby disabling the host from mounting an effective cellular immune response. To summarize, in addition to neutralizing host interferon-gamma at infected sites, we propose that M-T7 protein also modifies leukocyte traffic in the vicinity of virus lesions, thus effectively severing the link between antigen presenting cells of the infected tissue and the effector lymphocytes of the peripheral immune organs.

摘要

黏液瘤病毒是一种新大陆兔(棉尾兔属)的兔痘病毒,可在欧洲兔(穴兔属)中引发一种迅速致死的感染,即黏液瘤病。与所有痘病毒一样,黏液瘤病毒编码大量蛋白质以规避或抑制多种宿主抗病毒免疫机制。M-T7是黏液瘤病毒感染细胞中分泌量最高的蛋白质,最初被鉴定为干扰素-γ受体同源物(厄普顿、莫斯曼和麦克法登,《科学》258卷,1369 - 1372页,1992年)。在此,我们证明M-T7对于病毒在培养细胞中的复制并非必需,但对于欧洲兔体内病毒致病而言是关键的毒力因子。通过缺失372 bp的M-T7编码序列、用可选择标记p7.5Ecogpt进行替换并筛选对霉酚酸有抗性的重组病毒(vMyxlac-T7gpt),实现了黏液瘤病毒中两个M-T7基因拷贝的破坏。vMyxlac-T7gpt不表达可检测到的M-T7蛋白,其感染细胞的上清液也没有任何可检测到的干扰素-γ结合活性。用抗β-半乳糖苷酶和抗CD43抗体进行免疫组织化学染色表明,在感染vMyxlac-T7gpt的兔子中,M-T7的缺失不仅导致疾病症状显著减轻以及病毒向次要部位的传播减少,还极大地影响了宿主白细胞的行为。值得注意的是,野生型病毒感染的原发性损伤通常有大量炎症细胞,这些细胞并未有效迁移到病毒复制的真皮部位,而在感染vMyxlac-T7gpt时,这种白细胞流入的明显阻滞得到缓解。M-T7基因敲除病毒的另一个主要表型差异是,在感染第4天时,二级免疫器官,特别是脾脏和淋巴结中的淋巴细胞出现广泛激活。这与野生型黏液瘤病毒感染形成鲜明对比,野生型病毒感染在第4天时,脾脏和淋巴结生发中心的细胞激活相对较少(如果有的话)。我们得出结论,M-T7在感染早期发挥作用,一是阻碍炎症细胞迁移到感染组织中,二是破坏皮下原发性病毒感染部位的哨兵免疫细胞与二级淋巴器官中淋巴细胞之间的通讯,从而使宿主无法产生有效的细胞免疫反应。总之,除了在感染部位中和宿主干扰素-γ外,我们认为M-T7蛋白还改变了病毒损伤部位附近的白细胞运输,从而有效地切断了感染组织的抗原呈递细胞与外周免疫器官的效应淋巴细胞之间的联系。

相似文献

1
Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits.黏液瘤病毒M-T7是一种分泌型γ干扰素受体同源物,是欧洲兔黏液瘤病发展的关键毒力因子。
Virology. 1996 Jan 1;215(1):17-30. doi: 10.1006/viro.1996.0003.
2
The myxoma virus M-T4 gene encodes a novel RDEL-containing protein that is retained within the endoplasmic reticulum and is important for the productive infection of lymphocytes.黏液瘤病毒M-T4基因编码一种含新型RDEL的蛋白,该蛋白滞留在内质网中,对淋巴细胞的有效感染很重要。
Virology. 1997 Dec 22;239(2):360-77. doi: 10.1006/viro.1997.8894.
3
Role of the myxoma virus soluble CC-chemokine inhibitor glycoprotein, M-T1, during myxoma virus pathogenesis.黏液瘤病毒可溶性CC趋化因子抑制剂糖蛋白M-T1在黏液瘤病毒致病过程中的作用
Virology. 1999 Apr 10;256(2):233-45. doi: 10.1006/viro.1999.9617.
4
Disruption of M-T5, a novel myxoma virus gene member of poxvirus host range superfamily, results in dramatic attenuation of myxomatosis in infected European rabbits.M-T5是痘病毒宿主范围超家族的一个新型黏液瘤病毒基因成员,其破坏会导致感染欧洲兔的黏液瘤病显著减毒。
J Virol. 1996 Jul;70(7):4394-410. doi: 10.1128/JVI.70.7.4394-4410.1996.
5
SERP1, a serine proteinase inhibitor encoded by myxoma virus, is a secreted glycoprotein that interferes with inflammation.黏液瘤病毒编码的丝氨酸蛋白酶抑制剂SERP1是一种干扰炎症反应的分泌型糖蛋白。
Virology. 1993 Aug;195(2):348-63. doi: 10.1006/viro.1993.1385.
6
Myxoma virus M128L is expressed as a cell surface CD47-like virulence factor that contributes to the downregulation of macrophage activation in vivo.黏液瘤病毒M128L作为一种细胞表面CD47样毒力因子表达,它有助于在体内下调巨噬细胞的激活。
Virology. 2005 Jun 20;337(1):55-67. doi: 10.1016/j.virol.2005.03.037.
7
Coevolution of host and virus: the pathogenesis of virulent and attenuated strains of myxoma virus in resistant and susceptible European rabbits.宿主与病毒的共同进化:抗药性和易感性欧洲兔体内黏液瘤病毒强毒株和弱毒株的发病机制
Virology. 2000 Feb 1;267(1):36-48. doi: 10.1006/viro.1999.0104.
8
Coevolution of host and virus: cellular localization of virus in myxoma virus infection of resistant and susceptible European rabbits.宿主与病毒的协同进化:抗药和易感欧洲兔感染黏液瘤病毒时病毒的细胞定位
Virology. 2000 Nov 10;277(1):76-91. doi: 10.1006/viro.2000.0505.
9
Role of the C-terminal RDEL motif of the myxoma virus M-T4 protein in terms of apoptosis regulation and viral pathogenesis.黏液瘤病毒M-T4蛋白的C末端RDEL基序在细胞凋亡调控和病毒致病机制中的作用。
Virology. 1999 Oct 25;263(2):290-306. doi: 10.1006/viro.1999.9946.
10
Myxoma virus M141R expresses a viral CD200 (vOX-2) that is responsible for down-regulation of macrophage and T-cell activation in vivo.黏液瘤病毒M141R表达一种病毒CD200(vOX-2),它负责在体内下调巨噬细胞和T细胞的活化。
J Virol. 2005 May;79(10):6052-67. doi: 10.1128/JVI.79.10.6052-6067.2005.

引用本文的文献

1
The Role of Myxoma Virus Immune Modulators and Host Range Factors in Pathogenesis and Species Leaping.黏液瘤病毒免疫调节剂和宿主范围因子在发病机制及跨物种传播中的作用
Viruses. 2025 Aug 21;17(8):1145. doi: 10.3390/v17081145.
2
Identification of a Novel Myxoma Virus C7-Like Host Range Factor That Enabled a Species Leap from Rabbits to Hares.鉴定一种新型兔黏液瘤病毒 C7 样宿主范围因子,该因子使病毒能够实现从兔子到野兔的种间跳跃。
mBio. 2022 Apr 26;13(2):e0346121. doi: 10.1128/mbio.03461-21. Epub 2022 Mar 30.
3
Recombinant -Derived Immune Modulator M-T7 Accelerates Cutaneous Wound Healing and Improves Tissue Remodeling.
重组衍生免疫调节剂M-T7可加速皮肤伤口愈合并改善组织重塑。
Pharmaceutics. 2020 Oct 22;12(11):1003. doi: 10.3390/pharmaceutics12111003.
4
Viral Hormones: Expanding Dimensions in Endocrinology.病毒激素:内分泌学的扩展维度。
Endocrinology. 2019 Sep 1;160(9):2165-2179. doi: 10.1210/en.2019-00271.
5
Myxoma Virus dsRNA Binding Protein M029  Inhibits the Type I IFN-Induced Antiviral State in a  Highly Species-Specific Fashion.黏液瘤病毒双链RNA结合蛋白M029以高度物种特异性的方式抑制I型干扰素诱导的抗病毒状态。
Viruses. 2017 Feb 2;9(2):27. doi: 10.3390/v9020027.
6
Viral Inhibition of the IFN-Induced JAK/STAT Signalling Pathway: Development of Live Attenuated Vaccines by Mutation of Viral-Encoded IFN-Antagonists.病毒对 IFN 诱导的 JAK/STAT 信号通路的抑制:通过突变病毒编码的 IFN 拮抗剂开发减毒活疫苗。
Vaccines (Basel). 2016 Jun 29;4(3):23. doi: 10.3390/vaccines4030023.
7
Myxoma virus M156 is a specific inhibitor of rabbit PKR but contains a loss-of-function mutation in Australian virus isolates.黏液瘤病毒M156是兔PKR的特异性抑制剂,但在澳大利亚病毒分离株中存在功能丧失突变。
Proc Natl Acad Sci U S A. 2016 Apr 5;113(14):3855-60. doi: 10.1073/pnas.1515613113. Epub 2016 Feb 22.
8
A strategy to discover decoy chemokine ligands with an anti-inflammatory activity.一种发现具有抗炎活性的诱饵趋化因子配体的策略。
Sci Rep. 2015 Oct 7;5:14746. doi: 10.1038/srep14746.
9
Myxoma virus and the Leporipoxviruses: an evolutionary paradigm.黏液瘤病毒和兔痘病毒:一种进化范例。
Viruses. 2015 Mar 6;7(3):1020-61. doi: 10.3390/v7031020.
10
The α2,3-sialyltransferase encoded by myxoma virus is a virulence factor that contributes to immunosuppression.黏液瘤病毒编码的α2,3-唾液酸转移酶是一种有助于免疫抑制的毒力因子。
PLoS One. 2015 Feb 23;10(2):e0118806. doi: 10.1371/journal.pone.0118806. eCollection 2015.